ACETATE DE TERLIPRESSINE EVER PHARMA 0.2 mg/ml, solution for injection 5 bottles of 5 ml
Active ingredients: Terlipressin acetate, Terlipressin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACETATE DE TERLIPRESSINE EVER PHARMA 0,2 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- EVER VALINJECT (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Oct 2017
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69243168CIP75503124CIP133400955031246Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TERLIPRESSINEsolution | 0,17 mg · 1 ml de solution injectable | FT |
| ACÉTATE DE TERLIPRESSINEsolution | 0,2 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.